Diabetic Macular Edema (DME) Withdrawn Phase 4 Trials for Aflibercept (DB08885)

Also known as: Diabetic Macular Edema(DME) / Diabetic Macular Oedema / Macular Edema, Diabetic / Diabetic Macular Edema / Macular edema due to diabetes mellitus (disorder) / Diabetic retinal oedema / Diabetic retinal edema

DBCOND0060562 (Diabetic Macular Edema (DME))Withdrawn4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03059277Intravitreal Alfibercept for Center Involved DME Previously Managed With Intravitreal RanibizumabTreatment